Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1158-1161

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edfeldt, K.
Right arrow Articles by Yan, Z.-q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edfeldt, K.
Right arrow Articles by Yan, Z.-q.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Chronic ischemic heart disease

(Circulation. 2002;105:1158.)
© 2002 American Heart Association, Inc.


Brief Rapid Communications

Expression of Toll-Like Receptors in Human Atherosclerotic Lesions

A Possible Pathway for Plaque Activation

Kristina Edfeldt, MSc; Jesper Swedenborg, MD PhD; Göran K. Hansson, MD PhD; Zhong-qun Yan, MD PhD

From the Center for Molecular Medicine and the Department of Medicine (K.E., G.K.H., Z.-q.Y.) and the Department of Surgery (J.S.), Karolinska Institute, Stockholm, Sweden.

Correspondence to Dr Zhong-qun Yan, CMM L8:03, Karolinska Hospital, SE-17176 Stockholm, Sweden. E-mail Zhong-qun.Yan{at}cmm.ki.se

Background Innate immune reactions against bacteria and viruses have been implicated in the pathogenesis of atherosclerosis. To explore the molecular mechanism by which microbe recognition occurs in the artery wall, we characterized the expression of toll-like receptors (TLRs), a family of pathogen pattern recognition receptors, in atherosclerotic lesions.

Methods and Results Semiquantitative polymerase chain reaction and immunohistochemical analysis demonstrated that of 9 TLRs, the expression of TLR1, TLR2, and TLR4 was markedly enhanced in human atherosclerotic plaques. A considerable proportion of TLR-expressing cells were also activated, as shown by the nuclear translocation of nuclear factor-{kappa}B.

Conclusion Our findings illustrate a repertoire of TLRs associated with inflammatory activation in human atherosclerotic lesions, and they encourage further exploration of innate immunity in the pathogenesis of atherosclerosis.


Key Words: receptors • atherosclerosis • nuclear factor-{kappa}B • immune system




This article has been cited by other articles:


Home page
CirculationHome page
O. Pryshchep, W. Ma-Krupa, B. R. Younge, J. J. Goronzy, and C. M. Weyand
Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries
Circulation, September 16, 2008; 118(12): 1276 - 1284.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Versteeg, I E Hoefer, A H Schoneveld, D P V de Kleijn, E Busser, C Strijder, M Emons, P R Stella, P A Doevendans, and G Pasterkamp
Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve
Heart, June 1, 2008; 94(6): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Foglieni, F. Maisano, L. Dreas, A. Giazzon, G. Ruotolo, E. Ferrero, L. Li Volsi, S. Coli, G. Sinagra, B. Zingone, et al.
Mild inflammatory activation of mammary arteries in patients with acute coronary syndromes
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2831 - H2837.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. I. Duenas, M. Aceves, I. Fernandez-Pisonero, C. Gomez, A. Orduna, M. S. Crespo, and C. Garcia-Rodriguez
Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate
Cardiovasc Res, May 12, 2008; (2008) cvn087v2.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Malarstig, S. Sigurdsson, P. Eriksson, G. Paulsson-Berne, U. Hedin, L. Wallentin, A. Siegbahn, A. Hamsten, and A.-C. Syvanen
Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 975 - 982.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]


Home page
J. Exp. Med.Home page
A. E. Mullick, K. Soldau, W. B. Kiosses, T. A. Bell III, P. S. Tobias, and L. K. Curtiss
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
J. Exp. Med., February 18, 2008; 205(2): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
N. Fitzner, S. Clauberg, F. Essmann, J. Liebmann, and V. Kolb-Bachofen
Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands
Clin. Vaccine Immunol., January 1, 2008; 15(1): 138 - 146.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Westerterp, J. F.P. Berbee, N. M.M. Pires, G. J.D. van Mierlo, R. Kleemann, J. A. Romijn, L. M. Havekes, and P. C.N. Rensen
Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E Knockout Mice
Circulation, November 6, 2007; 116(19): 2173 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Shinohara, K.-i. Hirata, T. Yamashita, T. Takaya, N. Sasaki, R. Shiraki, T. Ueyama, N. Emoto, N. Inoue, M. Yokoyama, et al.
Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation: Synergism of TLR2 and TLR4
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2384 - 2391.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Niessner, M. S. Shin, O. Pryshchep, J. J. Goronzy, E. L. Chaikof, and C. M. Weyand
Synergistic Proinflammatory Effects of the Antiviral Cytokine Interferon-{alpha} and Toll-Like Receptor 4 Ligands in the Atherosclerotic Plaque
Circulation, October 30, 2007; 116(18): 2043 - 2052.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
Shuang Chen, M. H. Wong, D. J. Schulte, M. Arditi, and K. S. Michelsen
Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells
Innate Immunity, October 1, 2007; 13(5): 281 - 296.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Chen, E. Giovannucci, P. Kraft, R. Lazarus, and D. J. Hunter
Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1982 - 1989.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Lepper, C. Schumann, K. Triantafilou, F. M. Rasche, T. Schuster, H. Frank, E. M. Schneider, M. Triantafilou, and M. von Eynatten
Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men
J. Am. Coll. Cardiol., July 3, 2007; 50(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. K. Shah
Innate Immune Pathway Links Obesity to Insulin Resistance
Circ. Res., June 8, 2007; 100(11): 1531 - 1533.
[Full Text] [PDF]


Home page
Circ. Res.Home page
F. Kim, M. Pham, I. Luttrell, D. D. Bannerman, J. Tupper, J. Thaler, T. R. Hawn, E. W. Raines, and M. W. Schwartz
Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity
Circ. Res., June 8, 2007; 100(11): 1589 - 1596.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Danese, E. Dejana, and C. Fiocchi
Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation
J. Immunol., May 15, 2007; 178(10): 6017 - 6022.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Labrum, S. Bevan, M. Sitzer, M. Lorenz, and H. S. Markus
Toll Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Stroke, April 1, 2007; 38(4): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Linde, D. Mosier, F. Blecha, and T. Melgarejo
Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology
Cardiovasc Res, January 1, 2007; 73(1): 26 - 36.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Erridge, C. M. Spickett, and D. J. Webb
Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2
Cardiovasc Res, January 1, 2007; 73(1): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand
Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-{alpha}
Circulation, December 5, 2006; 114(23): 2482 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z.-q. Yan
Regulation of TLR4 Expression Is a Tale About Tail.
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2582 - 2584.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F.-Y. Lin, Y.-H. Chen, J.-S. Tasi, J.-W. Chen, T.-L. Yang, H.-J. Wang, C.-Y. Li, Y.-L. Chen, and S.-J. Lin
Endotoxin Induces Toll-Like Receptor 4 Expression in Vascular Smooth Muscle Cells via NADPH Oxidase Activation and Mitogen-Activated Protein Kinase Signaling Pathways
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2630 - 2637.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. Koch, P. Hoppmann, A. Pfeufer, A. Schomig, and A. Kastrati
Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population
Eur. Heart J., November 1, 2006; 27(21): 2524 - 2529.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Heidemann, W. Domschke, T. Kucharzik, and C. Maaser
Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?
Infect. Immun., October 1, 2006; 74(10): 5425 - 5432.
[Full Text] [PDF]


Home page
FASEB J.Home page
A. Jaulmes, S. Thierry, B. Janvier, M. Raymondjean, and V. Marechal
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1{beta}
FASEB J, August 1, 2006; 20(10): 1727 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. K. Mohammad, M. Morran, B. Slotterbeck, D. W. Leaman, Y. Sun, H. v. Grafenstein, S.-C. Hong, and M. F. McInerney
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
Int. Immunol., July 1, 2006; 18(7): 1101 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Yilmaz, C. Reiss, A. Weng, I. Cicha, C. Stumpf, A. Steinkasserer, W. G. Daniel, and C. D. Garlichs
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
J. Leukoc. Biol., March 1, 2006; 79(3): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Miyamoto, H. Yumoto, Y. Takahashi, M. Davey, F. C. Gibson III, and C. A. Genco
Pathogen-Accelerated Atherosclerosis Occurs Early after Exposure and Can Be Prevented via Immunization
Infect. Immun., February 1, 2006; 74(2): 1376 - 1380.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
F.C. Gibson III, H. Yumoto, Y. Takahashi, H.-H. Chou, and C.A. Genco
Innate Immune Signaling and Porphyromonas gingivalis-accelerated Atherosclerosis
J. Dent. Res., February 1, 2006; 85(2): 106 - 121.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Yumoto, H.-H. Chou, Y. Takahashi, M. Davey, F. C. Gibson III, and C. A. Genco
Sensitization of Human Aortic Endothelial Cells to Lipopolysaccharide via Regulation of Toll-Like Receptor 4 by Bacterial Fimbria-Dependent Invasion
Infect. Immun., December 1, 2005; 73(12): 8050 - 8059.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Yang, D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley
Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2308 - 2314.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Virmani, F. D. Kolodgie, A. P. Burke, A. V. Finn, H. K. Gold, T. N. Tulenko, S. P. Wrenn, and J. Narula
Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M Rattazzi, E Faggin, B Bertipaglia, and P Pauletto
Innate immunity and atherogenesis
Lupus, September 1, 2005; 14(9): 747 - 751.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Methe, J.-O. Kim, S. Kofler, M. Nabauer, and M. Weis
Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1439 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P.S. Olofsson, K. Jatta, D. Wagsater, S. Gredmark, U. Hedin, G. Paulsson-Berne, C. Soderberg-Naucler, G.K. Hansson, and A. Sirsjo
The Antiviral Cytomegalovirus Inducible Gene 5/Viperin Is Expressed in Atherosclerosis and Regulated by Proinflammatory Agents
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): e113 - e116.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. K. Hansson and K. Edfeldt
Toll To Be Paid at the Gateway to the Vessel Wall
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1085 - 1087.
[Full Text] [PDF]


Home page
CirculationHome page
H. Methe, J.-O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin
Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome
Circulation, May 24, 2005; 111(20): 2654 - 2661.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. K. Hansson
Inflammation, Atherosclerosis, and Coronary Artery Disease
N. Engl. J. Med., April 21, 2005; 352(16): 1685 - 1695.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Caligiuri, S. Kaveri, and A. Nicoletti
When Interleukin-18 Conducts, the Preludio Sounds the Same no Matter Who Plays
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 655 - 657.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A.H. Schoneveld, M.M. Oude Nijhuis, B. van Middelaar, J.D. Laman, D.P.V. de Kleijn, and G. Pasterkamp
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development
Cardiovasc Res, April 1, 2005; 66(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Z.H. Rittersma, J. A. Kremer Hovinga, K. T. Koch, S. M. Boekholdt, B. E. van Aken, A. Scheepmaker, M. Bax, C. E. Schotborgh, J. J. Piek, J. G.P. Tijssen, et al.
Relationship between In Vitro Lipopolysaccharide-Induced Cytokine Response in Whole Blood, Angiographic In-Stent Restenosis, and Toll-Like Receptor 4 Gene Polymorphisms
Clin. Chem., March 1, 2005; 51(3): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Nilsson, G. K. Hansson, and P. K. Shah
Immunomodulation of Atherosclerosis: Implications for Vaccine Development
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 18 - 28.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Y.L. Zee, H. H. Hegener, J. Gould, and P. M. Ridker
Toll-like Receptor 4 Asp299Gly Gene Polymorphism and Risk of Atherothrombosis
Stroke, January 1, 2005; 36(1): 154 - 157.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Stoll, G. M. Denning, and N. L. Weintraub
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. S. Michelsen, T. M. Doherty, P. K. Shah, and M. Arditi
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
J. Immunol., November 15, 2004; 173(10): 5901 - 5907.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. C. Mullaly and P. Kubes
Toll Gates and Traffic Arteries: From Endothelial TLR2 to Atherosclerosis
Circ. Res., October 1, 2004; 95(7): 657 - 659.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. Dunzendorfer, H.-K. Lee, and P. S. Tobias
Flow-Dependent Regulation of Endothelial Toll-Like Receptor 2 Expression Through Inhibition of SP1 Activity
Circ. Res., October 1, 2004; 95(7): 684 - 691.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Edfeldt, A. M Bennet, P. Eriksson, J. Frostegard, B. Wiman, A. Hamsten, G. K Hansson, U. d. Faire, and Z.-q. Yan
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction
Eur. Heart J., August 2, 2004; 25(16): 1447 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. Michelsen, M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
PNAS, July 20, 2004; 101(29): 10679 - 10684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Marson, R. M. Lawn, and T. Mikita
Oxidized Low Density Lipoprotein Blocks Lipopolysaccharide-induced Interferon {beta} Synthesis in Human Macrophages by Interfering with IRF3 Activation
J. Biol. Chem., July 2, 2004; 279(27): 28781 - 28788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S.-H. Kim, S. M. Lessner, Y. Sakurai, and Z. S. Galis
Cyclophilin A as a Novel Biphasic Mediator of Endothelial Activation and Dysfunction
Am. J. Pathol., May 1, 2004; 164(5): 1567 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Recalde, M. A. Ostos, E. Badell, A.-L. Garcia-Otin, J. Pidoux, G. Castro, M. M. Zakin, and D. Scott-Algara
Human Apolipoprotein A-IV Reduces Secretion of Proinflammatory Cytokines and Atherosclerotic Effects of a Chronic Infection Mimicked by Lipopolysaccharide
Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 756 - 761.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Pasterkamp, Z. S. Galis, and D. P.V. de Kleijn
Expansive Arterial Remodeling: Location, Location, Location
Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 650 - 657.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Li, T. Ha, J. Kelley, X. Gao, Y. Qiu, R. L Kao, W. Browder, and D. L Williams
Modulating Toll-like receptor mediated signaling by (1->3)-{beta}-D-glucan rapidly induces cardioprotection
Cardiovasc Res, February 15, 2004; 61(3): 538 - 547.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. C.G. Hollestelle, M. R. de Vries, J. K. van Keulen, A. H. Schoneveld, A. Vink, C. F. Strijder, B. J. van Middelaar, G. Pasterkamp, P. H.A. Quax, and D. P.V. de Kleijn
Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling
Circulation, January 27, 2004; 109(3): 393 - 398.
[Abstract] [Full Text] [PDF]